Urinary interleukin-2 may predict clinical outcome of intravesical bacillus Calmette-Gu�rin immunotherapy for carcinoma in situ of the bladder (Q73300442)
Jump to navigation
Jump to search
scientific article published on April 18, 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Urinary interleukin-2 may predict clinical outcome of intravesical bacillus Calmette-Gu�rin immunotherapy for carcinoma in situ of the bladder |
scientific article published on April 18, 2003 |
Statements
Urinary interleukin-2 may predict clinical outcome of intravesical bacillus Calmette-Guérin immunotherapy for carcinoma in situ of the bladder (English)
Urinary interleukin-2 may predict clinical outcome of intravesical bacillus Calmette-Gu�rin immunotherapy for carcinoma in situ of the bladder (English)
1 reference
1 reference
1 reference
Hideyasu Matsuyama
Etsuya Watanabe
Kenji Matsuda
Chietaka Ohmi
Yasuhide Tei
Satoru Yoshihiro
Yasukazu Ohmoto
Katsusuke Naito
18 April 2003
1 reference
1 reference